The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.

Bingham, S; Beswick, P; Bountra, C; Brown, T; Campbell, I; Chessell, I; Clayton, N; Collins, S; Davey, P; Goodland, H; Gray, N; Haslam, C; Hatcher, J; Hunter, A; Lucas, F; Murkitt, G; Naylor, A; Pickup, E; Sargent, B; Summerfield, S; Stevens, A; Stratton, S; Wiseman, J

Journal article

The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.

Abstract:: The pathogenic form of the cyclooxygenase (COX) enzyme, COX-2, is also constitutively present in the spinal cord and has been implicated in chronic pain states in rat and man. A number of COX-2 inhibitors, including celecoxib and rofecoxib, are already used in man for the treatment of inflammatory pain. Preclinically, the dual-acting COX-2 inhibitor, GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine, where X denotes the free base], is as effective as rofecox...
Expand abstract
Collapse abstract

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Bingham, S., Beswick, P., Bountra, C., Brown, T., Campbell, I., Chessell, I., Clayton, N., Collins, S., Davey, P., Goodland, H., Gray, N., Haslam, C., Hatcher, J., Hunter, A., Lucas, F., Murkitt, G., Naylor, A., Pickup, E., Sargent, B., … Wiseman, J. (2016). The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. Journal of Pharmacology and Experimental Therapeutics, 312(3), 1161–1169.

MLA Style

Bingham, S., et al. “The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(Methylsulfonyl)Phenyl]-Pyrazolo[1,5-b]Pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization.” Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 3, 2016, pp. 1161–69.

Chicago Style

Bingham, S, P Beswick, C Bountra, T Brown, I Campbell, I Chessell, N Clayton, et al. 2016. “The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(Methylsulfonyl)Phenyl]-Pyrazolo[1,5-b]Pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization.” Journal of Pharmacology and Experimental Therapeutics 312 (3): 1161–69.
Tweet
Print